1. A Canadian Working Group Report on Fecal Microbial Therapy: Microbial Ecosystems Therapeutics
2. Anon(2013a)Food and Drug Administration Center for Biologics Evaluation and Research U.S. Department of Health and Human ServicesLetter to C. Richard Boland MD AGAF Chair American Gastroenterological Association.http://www.naspghan.org/files/documents/FDA%20response%20letter%20to%20FMT%20Inquiry.pdfAccessed April 1 2015.
3. Anon(2013b)Food and Drug Administration Center for Biologics Evaluation and Research U.S. Department of Health and Human Services. Guidance for industry. Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies.http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htmAccessed April 1 2015.
4. Anon(2015)The OpenBiome Quality and Safety Program (Q&SP) Full Packet.http://static1.squarespace.com/static/50e0c29ae4b0a05702af7e6a/t/5565feabe4b0bdf8e9e2e433/1432747691066/The+OpenBiome+Quality+%26+Safety+Program.pdfAccessed June 5 2015.
5. Fecal microbiota transplantation